GeneFerm Biotechnology Co. Ltd.(TW:1796)
NT$28.00+0.45 (+1.63%)
TW:1796
GeneFerm Biotechnology Co. Ltd. financials statements
NT$28.00
At close:+0.45 (+1.63%)
GeneFerm Biotechnology Co. Ltd. (1796) Income Statement
GeneFerm Biotechnology Co. Ltd. Income Statement
Last quarter (Q2 2026), GeneFerm Biotechnology Co. Ltd.'s total revenue was NT$168.93M, an increase of 0.64% from the same quarter last year. In Q2, GeneFerm Biotechnology Co. Ltd.'s net income was NT$2.27M. See GeneFerm Biotechnology Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 677.10M | NT$ 521.16M | NT$ 793.77M | NT$ 633.96M | NT$ 522.33M | |
| NT$ 190.80M | NT$ 96.75M | NT$ 286.35M | NT$ 222.16M | NT$ 192.65M | |
| NT$ 144.76M | NT$ 132.24M | NT$ 132.79M | NT$ 120.89M | NT$ 112.38M | |
| Depreciation and Amortization | NT$ 74.48M | NT$ 79.36M | NT$ 73.49M | NT$ 50.03M | NT$ 45.36M |
| NT$ 115.40M | NT$ 56.34M | NT$ 231.09M | NT$ 163.34M | NT$ 124.51M | |
| NT$ 46.04M | NT$ -35.49M | NT$ 153.56M | NT$ 113.31M | NT$ 79.15M | |
| NT$ -11.34M | NT$ 6.94M | NT$ -132.00K | NT$ -3.10M | NT$ -9.88M | |
| NT$ 34.70M | NT$ -27.46M | NT$ 153.43M | NT$ 110.21M | NT$ 70.40M | |
| NT$ 28.86M | NT$ -22.53M | NT$ 124.62M | NT$ 93.45M | NT$ 57.41M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 0.70 | NT$ -0.54 | NT$ 3.01 | NT$ 2.26 | NT$ 1.45 |
| Diluted EPS | NT$ 0.70 | NT$ -0.54 | NT$ 2.99 | NT$ 2.20 | NT$ 1.32 |
| Weighted Average Shares Outstanding | 41.46M | 41.46M | 41.40M | 41.35M | 39.68M |
| Weighted Average Shares Outstanding (Diluted) | 41.48M | 41.46M | 41.61M | 42.58M | 46.28M |
Currency in TWD
